Przegląd Gastroenterologiczny

Full text

2/2026 vol. 21

Gastroenterological disorders in inborn errors of immunity. Part 2 B. Overview of selected diseases

  1. Department of Allergology, Clinical Immunology, and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

  2. Student Research Club of Clinical Immunology, Department of Allergology, Clinical Immunology, and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland

Gastroenterology Rev 2026; 21 (2): 135–138

Data publikacji online: 2026/06/01
Article file
Gastroenterological disorders (2).pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42: 1473-507.
  2. Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol 2022; 42: 1508-20.
  3. Skokowa J, Dale DC, Touw IP, et al. Severe congenital neutropenias. Nat Rev Dis Primers 2017; 3: 17032.
  4. Aydogmus C, Cipe F, Tas M, et al. HAX-1 deficiency: characteristics of five cases including an asymptomatic patient. Asian Pac J Allergy Immunol 2016; 34: 73-6.
  5. Justiz-Vaillant AA, Williams-Persad AFA, Arozarena-Fundora R, et al. Chronic granulomatous disease (CGD): commonly associated pathogens, diagnosis and treatment. Microorganisms 2023; 11: 2233.
  6. Napiórkowska-Baran K, Darwish S, Kaczor J, et al. Oral diseases as a manifestation of inborn errors of immunity. J Clin Med 2024; 13: 5079.
  7. Mohammadi F, Yadegar A, Mardani M, et al. Organ-based clues for diagnosis of inborn errors of immunity: a practical guide for clinicians. Immun Inflamm Dis 2023; 11: e833.
  8. Jung S, Gies V, Korganow AS, et al. Primary Immunodeficiencies with defects in innate immunity: focus on orofacial manifestations. Front Immunol 2020; 11: 1065.
  9. Errami A, El Baghdadi J, Ailal F, et al. Mendelian susceptibility to mycobacterial disease (MSMD): clinical, immunological and genetic features of 22 patients from 15 Moroccan kindreds. J Clin Immunol 2023; 43: 728-40.
  10. Bustamante J, Boisson-Dupuis S, Abel L, et al. Susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-g immunity. Semin Immunol 2014; 26: 454-70.
  11. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11: 321-33.
  12. Khoshnevisan R, Nekooei-Marnany N, Klein C., et al. IL-12Rb1 deficiency corresponding to concurrency of two diseases, mendelian susceptibility to mycobacterial disease and Crohn’s disease. J Clin Tuberc Other Mycobact Dis 2019; 17: 100123.
  13. Vavassori S, Chou J, Faletti LE, et al. Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency. J Allergy Clin Immunol 2021; 148: 381-93.
  14. Lopes JP, Lionakis MS. Pathogenesis and virulence of candida albicans. Virulence 2021; 13: 89-121.
  15. Qian G, Zhang J, Shi L, et al. Chinese chronic mucocutaneous candidiasis: a case report series. Infect Drug Resist 2024; 17: 1869-77.
  16. van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Infect 2016; 72: S56-60.
  17. Maglione PJ, Simchoni N, Cunningham-Rundles C. Toll-like receptor signaling in primary immune deficiencies. Ann N Y Acad Sci 2015; 1356: 1-21.
  18. Tufan A, Lachmann HJ. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci 2020; 50: 1591-610.
  19. Cudrici C, Deuitch N, Aksentijevich I. Revisiting TNF receptor-associated periodic syndrome (TRAPS): current perspectives. Int J Mol Sci 2020; 21: 3263.
  20. Sinnathamby ES, Issa PP, Roberts L, et al. Hereditary angioedema: diagnosis, clinical implications, and pathophysiology. Adv Ther 2023; 40: 814-27.
  21. Dufour C, Pierri F. Modern management of fanconi anemia. Hematology 2022; 2022: 649-57.
  22. Mehta PA, Ebens C. Fanconi Anemia. University of Washington, Seattle: Seattle (WA), 1993.
  23. Clinical Care of Fanconi Anemia Gastrointestinal Issues. Fanconi Cancer Foundation.
  24. Niedokrwistość Aplastyczna Fanconiego - Niedokrwistości Aplastyczne Wrodzone - Niedokrwistości Aplastyczne - Niedokrwistości Spowodowane Zaburzeniami Wytwarzania Krwinek Czerwonych i Hemoglobiny - Niedokrwistości - Hematologia i Onkologia - Pediatria - Podręcznik Multimedialny Oparty Na Zasadach EBM - Medycyna Praktyczna.
  25. Narumi S. Discovery of MIRAGE syndrome. Pediatr Int 2022; 64: e15283.
  26. Tanase-Nakao K, Olson TS, Narumi S. MIRAGE Syndrome. In GeneReviews®; University of Washington, Seattle: Seattle (WA), 1993.
  27. Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program 2011; 2011: 480-6.
  28. Garofola C, Nassereddin A, Gross GP. Dyskeratosis Congenita. In StatPearls; StatPearls Publishing: Treasure Island (FL), 2024.
  29. Coats plus Syndrome - NIH Genetic Testing Registry (GTR) - NCBI Available online: https://www.ncbi.nlm.nih.gov/gtr/conditions/C2677299/ (accessed on 8 May 2024).
  30. Hoşnut FÖ, Şahin G, Akçaboy M. Coats Plus syndrome: a diagnostic and therapeutic challenge in pediatric gastrointestinal hemorrhage. Turk J Pediatr 2022; 64: 166-70.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees